406 related articles for article (PubMed ID: 16338491)
21. Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures.
Marianna P; Kollia P; Akel S; Papassotiriou Y; Stamoulakatou A; Loukopoulos D
Haematologica; 2001 Jul; 86(7):700-5. PubMed ID: 11454524
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin and hydroxyurea can act on early erythroid progenitors from adult human peripheral blood to modulate fetal globin mRNA levels.
Stoeckert CJ; Green MB
Exp Hematol; 1994 Mar; 22(3):278-82. PubMed ID: 8112426
[TBL] [Abstract][Full Text] [Related]
23. Cytokine-induced apoptosis of beta-thalassemia/hemoglobin E erythroid progenitor cells via nitric oxide-mediated process in vitro.
Kheansaard W; Panichob P; Fucharoen S; Tanyong DI
Acta Haematol; 2011; 126(4):224-30. PubMed ID: 21934298
[TBL] [Abstract][Full Text] [Related]
24. Fetal globin induction in beta-thalassemia.
El-Beshlawy A; Hamdy M; El Ghamrawy M
Hemoglobin; 2009; 33 Suppl 1():S197-203. PubMed ID: 20001626
[TBL] [Abstract][Full Text] [Related]
25. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
Italia KY; Jijina FF; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
[TBL] [Abstract][Full Text] [Related]
26. Rapamycin-mediated induction of gamma-globin mRNA accumulation in human erythroid cells.
Mischiati C; Sereni A; Lampronti I; Bianchi N; Borgatti M; Prus E; Fibach E; Gambari R
Br J Haematol; 2004 Aug; 126(4):612-21. PubMed ID: 15287957
[TBL] [Abstract][Full Text] [Related]
27. Reduction of the clinical severity of sickle cell/beta-thalassemia with hydroxyurea: the experience of a single center in Greece.
Loukopoulos D; Voskaridou E; Kalotychou V; Schina M; Loutradi A; Theodoropoulos I
Blood Cells Mol Dis; 2000 Oct; 26(5):453-66. PubMed ID: 11112383
[TBL] [Abstract][Full Text] [Related]
28. Treatment of beta-thalassemia with hydroxyurea (HU)--effects of HU on globin gene expression.
Huang SZ; Ren ZR; Chen MJ; Xu HP; Zeng YT; Rodgers GP; Zeng FY; Schechter AN
Sci China B; 1994 Nov; 37(11):1350-9. PubMed ID: 7865126
[TBL] [Abstract][Full Text] [Related]
29. Hydroxamide derivatives of short-chain fatty acid have erythropoietic activity and induce gamma gene expression in vivo.
Cao H; Jung M; Stamatoyannopoulos G
Exp Hematol; 2005 Dec; 33(12):1443-9. PubMed ID: 16338486
[TBL] [Abstract][Full Text] [Related]
30. Genetic determinants related to pharmacological induction of foetal haemoglobin in transfusion-dependent HbE-β thalassaemia.
Biswas S; Nag A; Ghosh K; Ray R; Roy K; Bandyopadhyay A; Bhattacharyya M
Ann Hematol; 2019 Feb; 98(2):289-299. PubMed ID: 30413899
[TBL] [Abstract][Full Text] [Related]
31. A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials.
Felice AE; Borg J; Pizzuto M; Cassar W; Galdies R; Wettinger SB; Pulis S; Hunter GJ; Caruana MR; Farrugia M; Scerri CA
Hemoglobin; 2007; 31(2):279-88. PubMed ID: 17486512
[TBL] [Abstract][Full Text] [Related]
32. Differential regulation of A gamma and G gamma fetal hemoglobin mRNA levels by hydroxyurea and butyrate.
Xu J; Zimmer DB
Exp Hematol; 1998 Mar; 26(3):265-72. PubMed ID: 9502623
[TBL] [Abstract][Full Text] [Related]
33. Response to hydroxyurea treatment in Iranian transfusion-dependent beta-thalassemia patients.
Yavarian M; Karimi M; Bakker E; Harteveld CL; Giordano PC
Haematologica; 2004 Oct; 89(10):1172-8. PubMed ID: 15477200
[TBL] [Abstract][Full Text] [Related]
34. Comparison of MicroRNAs Mediated in Reactivation of the γ-Globin in β-Thalassemia Patients, Responders and Non-Responders to Hydroxyurea.
Hojjati MT; Azarkeivan A; Pourfathollah AA; Amirizadeh N
Hemoglobin; 2017 Mar; 41(2):110-115. PubMed ID: 28696844
[TBL] [Abstract][Full Text] [Related]
35. Fetal hemoglobin chemical inducers for treatment of hemoglobinopathies.
Testa U
Ann Hematol; 2009 Jun; 88(6):505-28. PubMed ID: 19011856
[TBL] [Abstract][Full Text] [Related]
36. Disorders of the synthesis of human fetal hemoglobin.
Manca L; Masala B
IUBMB Life; 2008 Feb; 60(2):94-111. PubMed ID: 18379999
[TBL] [Abstract][Full Text] [Related]
37. Response to hydroxyurea therapy in beta-thalassemia.
Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
[TBL] [Abstract][Full Text] [Related]
38. DNA hypomethylation therapy for hemoglobin disorders: molecular mechanisms and clinical applications.
Fathallah H; Atweh GF
Blood Rev; 2006 Jul; 20(4):227-34. PubMed ID: 16513230
[TBL] [Abstract][Full Text] [Related]
39. Desensitization to hydroxycarbamide following long-term treatment of thalassaemia intermedia as observed in vivo and in primary erythroid cultures from treated patients.
Rigano P; Pecoraro A; Calzolari R; Troia A; Acuto S; Renda D; Pantalone GR; Maggio A; Di Marzo R
Br J Haematol; 2010 Dec; 151(5):509-15. PubMed ID: 20955403
[TBL] [Abstract][Full Text] [Related]
40. A Formula to Identify Potential Cases of β-Thalassemia/HbE Disease Among Patients With Absent HbA, HbE >75% and HbF Between 5 and 15.
Pornprasert S; Tookjai M; Punyamung M; Kongthai K
Lab Med; 2019 Apr; 50(2):158-162. PubMed ID: 30239825
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
